SAN DIEGO, April 28 /PRNewswire/ -- PURE Bioscience (Nasdaq: PURE), creators of the patented silver dihydrogen citrate (SDC) antimicrobial, announced today that its distributor, BioTech Medical, LLC, is well-positioned to immediately respond to the current swine flu emergency with its SDC-based SpectraSan 24(TM) disinfectant. SpectraSan 24, which meets the recommendations by the United States Centers for Disease Control (CDC) for infection control for care of patients with confirmed or suspected Swine Influenza A (H1N1) virus in both home and healthcare settings.
Andrea L. Goren, Executive Director of BioTech Medical, LLC, stated, "We are prepared and well-positioned to supply a much needed preventative solution to this potentially dangerous swine flu outbreak. BioTech Medical has a long-term history of successfully selling innovative healthcare products through various market channels and representative groups to multiple segments of the healthcare industry, including hospitals, long-term care facilities, clinics and doctors' offices throughout the United States as well as internationally."
Ms. Goren continued, "In addition to our existing marketing organization, we have the staff, warehousing facilities, distribution capability and capital resources to rapidly deliver SpectraSan 24 to all facets of not only healthcare but also institutions, businesses and the hospitality industry. We also have entree into schools, day care, athletic facilities and all modes of transportation such as airlines, cruise lines, rail and bus lines including all regional transit authorities. We also intend to offer SpectraSan 24 directly to consumers and through retail outlets in conjunction with our parent company, SCI Industries."
According to the CDC, person-to-person transmission of flu occurs mainly through coughing or sneezing
|SOURCE BioTech Medical, LLC|
Copyright©2009 PR Newswire.
All rights reserved